Abstract
Vascular endothelial growth factor (VEGF) and its receptor kinase insert domain-containing receptor (KDR) pathway trigger the process of angiogenesis as well as inflammation, which contributes to the development and progression of demyelinating lesions in multiple sclerosis. This work is a case–control study comprising of a total of 400 subjects with multiple sclerosis and 400 healthy controls. Participants were subjected to neurological examination and peripheral blood sampling for genotyping. Polymorphisms in the VEGF and KDR genes were assessed using the restriction fragment length polymorphism (RFLP-PCR) method. A significantly higher frequency of the T allele and TT genotype of the VEGF 936C > T (rs3025039) polymorphism was found in the multiple sclerosis group than in the healthy control group (P = 0.01 [OR = 1.41] and P = 0.01 [OR = 3.12], respectively). In addition, VEGF 936C > T showed an association with patients in a recessive model. However, the KDR -604T > C (rs2071559) polymorphism showed no significant difference in either allelic or genotype frequency between the two groups. Taken together, the results of the present study suggests that the T allele of the rs3025039 in VEGF gene could be considered a risk factor for developing multiple sclerosis in the Iranian population.
Similar content being viewed by others
References
Abhinand CS, Raju R, Soumya SJ, Arya PS, Sudhakaran PR (2016) VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis. J Cell Commun Signal :1–8
Al-Habboubi HH, Sater MS, Almawi AW, Al-Khateeb GM, Almawi WY (2011) Contribution of VEGF polymorphisms to variation in VEGF serum levels in a healthy population. Eur Cytokine Netw 22:154–158
An S-J, Chen Z-H, Lin Q-X, Su J, Chen H-J, Lin J-Y, Wu Y-L (2009) The-271 G> a polymorphism of kinase insert domain-containing receptor gene regulates its transcription level in patients with non-small cell lung cancer. BMC Cancer 9:1
Angelo LS, Kurzrock R (2007) Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin Cancer Res 13:2825–2830
Argaw AT, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG (2012) Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest 122:2454–2468
Dassoulas K, Gazouli M, Rizos S, Theodoropoulos G, Christoni Z, Nikiteas N, Karakitsos P (2009) Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog 48:563–569
Eftekharian MM, Noroozi R, Sayad A, Sarrafzadeh S, Toghi M, Azimi T, Komaki A, Mazdeh M, Inoko H, Taheri M (2016) RAR-related orphan receptor a (RORA): a new susceptibility gene for multiple sclerosis. J Neurol Sci 369:259–262
Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi S-H, Akbari M, Fereidan-Esfahani M (2013) Epidemiology of multiple sclerosis in Iran: a systematic review. Eur Neurol 70:356–363
Girolamo F, Coppola C, Ribatti D, Trojano M (2014) Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis. Acta Neuropathol Commun 2:1
Gogat KN, Le Gat L, Van Den Berghe LC, Marchant D, Kobetz A, Gadin SP, Gasser B, Quéré I, Abitbol M, Menasche M (2004) VEGF and KDR gene expression during human embryonic and fetal eye development. Invest Ophthalmol Vis Sci 45:7–14
Gunesacar R, Erken E, Ozer H, Bozkurt B, Dinkci S, Deveci D (2008) Analysis of vascular endothelial growth factor gene 936 C/T polymorphism in patients with familial Mediterranean fever. Int J Immunogenet 35:33–36
Hansen TF, Sørensen FB, Spindler K-LG, Olsen DA, Andersen RF, Lindebjerg J, Brandslund I, Jakobsen A (2010) Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer. Virchows Arch 456:251–260
Iacobaeus E, Amoudruz P, Ström M, Khademi M, Brundin L, Hillert J, Kockum I, Malmström V, Olsson T, Tham E (2011) The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis. PLoS One 6:e19138
Jang MJ, Jeon YJ, Kim JW, Cho YK, Lee SK, Hwang SG, Oh D, Kim NK (2013) Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans. Mol Carcinog 52:60–69
Kim JG, Chae YS, Sohn SK, Cho YY, Moon JH, Park JY, Jeon SW, Lee IT, Choi GS, Jun S-H (2008) Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res 14:62–66
Kim MK, Suh C, Chi HS, Cho HS, Bae YK, Lee KH, Lee GW, Kim IS, Eom HS, Kong SY (2012b) VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma. Cancer Sci 103:497–503
Kim JJ, Vaziri SA, Rini BI, Elson P, Garcia JA, Wirka R, Dreicer R, Ganapathi MK, Ganapathi R (2012a) Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib. Cancer 118:1946–1954
Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E, Siviridis E (2004) VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46:293–298
Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J, Samonigg H (2003) A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106:468–471
Liu Y, Hou S, Lang W, Dai D, Wang Z, Ji X, Li K, Zhang X, Zou Y, Wang J (2014) Roles of three common VEGF polymorphisms in the risk of age-related macular degeneration. Genet Test Mol Biomarkers 18:245–252
Mazdeh M, Taheri M, Sayad A, Bahram S, Omrani MD, Movafagh A, Inoko H, Akbari MT, Noroozi R, Hajilooi M (2016) HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis. Pharmacogenomics 17:489–498
Miller D, Barkhof F, Berry I, Kappos L, Scotti G, Thompson A (1991) Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 54:683–688
Nazdik MK, Taheri M, Omrani MD, Sajjadi E, Arsang-Jang S, Koohpar ZK, Inoko H, Sayad A (2016) Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients. Hum Antibodies :1–5
Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ (2002) Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol 61:914–925
Rah H, Jeon YJ, Choi Y, Shim SH, Ko JJ, Yoon TK, Cha SH, Kim NK (2012) Association between kinase insert domain-containing receptor polymorphisms (− 604T> C, 1192G> a, 1719A> T) and premature ovarian failure in Korean women. Menopause 19:1037–1042
Rahim M, El Khoury LY, Raleigh SM, Ribbans WJ, Posthumus M, Collins M, September AV (2016) Human genetic variation, sport and exercise medicine, and Achilles Tendinopathy: role for angiogenesis-associated genes. OMICS: J Integr Biol 20:520–527
Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E (2001) A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37:443–448
Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow J (2008) Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. J Clin Oncol 26:4672–4678
Shahsavari S, Noormohammadi Z, Karizi SZ (2015) Association of kinase insert domain-containing receptor (KDR) gene polymorphism/haplotypes with recurrent spontaneous abortion and genetic structure. Int J Reprod BioMed 13:755
Su M-T, Lin, S-H, Lee I-W, Chen Y-C, Kuo P-L (2011) Association of polymorphisms/haplotypes of the genes encoding vascular endothelial growth factor and its KDR receptor with recurrent pregnancy loss. Human Reprod :deq401
Taheri M, Nemati S, Movafagh A, Eftekharian MM, Mirfakhraie R, Saberi M, Mazdeh M, Sayad A (2016) TRAIL gene expression analysis in multiple sclerosis patients. Hum Antibodies :1–6
Wang Y, Zheng Y, Zhang W, Yu H, Lou K, Zhang Y, Qin Q, Zhao B, Yang Y, Hui R (2007) Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol 50:760–767
Wu Y, Zhang Y, Han X, Li X, Xue L, Xie A (2016) Association of VEGF gene polymorphisms with sporadic Parkinson’s disease in Chinese Han population. Neurol Sci, :1–7
Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG (2003) Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complicat 17:1–6
Yang C, Feng X, Huang Z, Li M, Qiu X (2016) Diversity and frequency of kdr mutations within Anopheles Sinensis populations from Guangxi, China. Malar J 15:411
Acknowledgements
This study was supported financially by the Hamadan University of Medical Sciences (grant no. 950221643).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Mazdeh, M., Noroozi, R., Gharesouran, J. et al. The Importance of VEGF-KDR Signaling Pathway Genes should Not Be Ignored When the Risk of Developing Multiple Sclerosis is Taken into Consideration. J Mol Neurosci 62, 73–78 (2017). https://doi.org/10.1007/s12031-017-0912-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-017-0912-2